Following the 2015 release of its cognitive computing platform, Iris, Silicon Valley based Apixio Inc. is now on the verge of receiving the necessary financial backing to push itself to the forefront of health data utilization. On Tuesday, the company announced its fifth round of investment, also known as Series D funding, totaling $19.3 million. It comes on the back of the success of Apixio’s HCC Profiler Solution, a method of computing patient risk scores by looking at chronic condition data, clinical medical charts and medical billing data. This helps streamline processes for care delivery and provider payment for patients enrolled in Medicare Advantage.